Suppression of Experimental Membranous Glomerulonephritis in Rats by an Anti-MHC Class II Antibody

Abstract

The present results demonstrated that the MHC class II molecule itself is directly involved in the pathogenesis of HN, and suggest that this therapy would be any better (or less toxic) than nonselective immunosuppressants in the treatment of IMN.